Here, we disrupted Pten and p53 in mammary epithelium either alone orin combination and determined the effect on tumor formation, tumor-initiating cells, prognosis,PI3K/AKT pathway activation and response to therapeutic drugs. The gene discussed is AKT1; the disease is neoplasm.